VCAM1 and Increased total eosinophil count: One hypothesis suggests that dupilumab‐induced eosinophilia results from altered vascular cell adhesion molecule‐1 (VCAM‐1) expression, a key molecule mediating eosinophil adhesion to endothelial cells.